DE69200948D1 - Verwendung von Benzimidazolin-2-oxo-1-Carbonsäurederivaten bei der Behandlung organischer Gehirnerkrankungen. - Google Patents

Verwendung von Benzimidazolin-2-oxo-1-Carbonsäurederivaten bei der Behandlung organischer Gehirnerkrankungen.

Info

Publication number
DE69200948D1
DE69200948D1 DE69200948T DE69200948T DE69200948D1 DE 69200948 D1 DE69200948 D1 DE 69200948D1 DE 69200948 T DE69200948 T DE 69200948T DE 69200948 T DE69200948 T DE 69200948T DE 69200948 D1 DE69200948 D1 DE 69200948D1
Authority
DE
Germany
Prior art keywords
benzimidazoline
oxo
treatment
carboxylic acid
acid derivatives
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired - Fee Related
Application number
DE69200948T
Other languages
English (en)
Other versions
DE69200948T2 (de
Inventor
Alessandro Brambilla
Marco Turconi
Pierino Schiantarelli
Franco Borsini
Herbert Ladinsky
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Boehringer Ingelheim Italia SpA
Original Assignee
Boehringer Ingelheim Italia SpA
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Boehringer Ingelheim Italia SpA filed Critical Boehringer Ingelheim Italia SpA
Publication of DE69200948D1 publication Critical patent/DE69200948D1/de
Application granted granted Critical
Publication of DE69200948T2 publication Critical patent/DE69200948T2/de
Anticipated expiration legal-status Critical
Expired - Fee Related legal-status Critical Current

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/41—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with two or more ring hetero atoms, at least one of which being nitrogen, e.g. tetrazole
    • A61K31/415—1,2-Diazoles
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/18—Antipsychotics, i.e. neuroleptics; Drugs for mania or schizophrenia
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/28—Drugs for disorders of the nervous system for treating neurodegenerative disorders of the central nervous system, e.g. nootropic agents, cognition enhancers, drugs for treating Alzheimer's disease or other forms of dementia
DE69200948T 1991-07-04 1992-07-02 Verwendung von Benzimidazolin-2-oxo-1-Carbonsäurederivaten bei der Behandlung organischer Gehirnerkrankungen. Expired - Fee Related DE69200948T2 (de)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
ITMI911845A IT1250629B (it) 1991-07-04 1991-07-04 Uso dei derivati dell'acido benzimidazolin-2-oxo-1-carbossilico.

Publications (2)

Publication Number Publication Date
DE69200948D1 true DE69200948D1 (de) 1995-02-02
DE69200948T2 DE69200948T2 (de) 1995-05-18

Family

ID=11360276

Family Applications (1)

Application Number Title Priority Date Filing Date
DE69200948T Expired - Fee Related DE69200948T2 (de) 1991-07-04 1992-07-02 Verwendung von Benzimidazolin-2-oxo-1-Carbonsäurederivaten bei der Behandlung organischer Gehirnerkrankungen.

Country Status (17)

Country Link
EP (1) EP0523013B1 (de)
JP (1) JPH05194216A (de)
KR (1) KR930001906A (de)
AT (1) ATE115857T1 (de)
AU (1) AU658197B2 (de)
CA (1) CA2072911A1 (de)
DE (1) DE69200948T2 (de)
DK (1) DK0523013T3 (de)
GR (1) GR3015413T3 (de)
HU (2) HUT61462A (de)
IE (1) IE922174A1 (de)
IL (1) IL102381A0 (de)
IT (1) IT1250629B (de)
MX (1) MX9203900A (de)
NO (1) NO922635L (de)
TW (1) TW202386B (de)
ZA (1) ZA924949B (de)

Families Citing this family (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JPH05310732A (ja) * 1992-03-12 1993-11-22 Mitsubishi Kasei Corp シンノリン−３−カルボン酸誘導体
JP2699794B2 (ja) * 1992-03-12 1998-01-19 三菱化学株式会社 チエノ〔３，２−ｂ〕ピリジン誘導体
WO2001042224A1 (en) * 1999-12-09 2001-06-14 Mitsubishi Pharma Corporation Carboxyamido derivatives
EP1861377B1 (de) * 2005-03-15 2010-12-29 Pfizer, Inc. Benzimidazolonderivate als cb2-rezeptor-liganden

Family Cites Families (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4605652A (en) * 1985-02-04 1986-08-12 A. H. Robins Company, Inc. Method of enhancing memory or correcting memory deficiency with arylamido (and arylthioamido)-azabicycloalkanes
DE3752062T2 (de) * 1986-12-17 1997-09-11 Glaxo Group Ltd Verwendung von heterozyklischen Derivaten zur Herstellung von Arzneimitteln
IT1231413B (it) * 1987-09-23 1991-12-04 Angeli Inst Spa Derivati dell'acido benzimidazolin-2-osso-1-carbossilico utili come antagonisti dei recettori 5-ht
US4887422A (en) * 1988-09-06 1989-12-19 Amsted Industries Incorporated Rope with fiber core and method of forming same

Also Published As

Publication number Publication date
AU658197B2 (en) 1995-04-06
EP0523013A3 (de) 1993-01-27
TW202386B (de) 1993-03-21
NO922635L (no) 1993-01-05
AU1938192A (en) 1993-01-07
ITMI911845A0 (it) 1991-07-04
ATE115857T1 (de) 1995-01-15
IT1250629B (it) 1995-04-21
HU211855A9 (en) 1995-12-28
HU9202229D0 (en) 1992-10-28
MX9203900A (es) 1993-01-01
GR3015413T3 (en) 1995-06-30
IE922174A1 (en) 1993-01-13
EP0523013B1 (de) 1994-12-21
ZA924949B (en) 1994-01-03
DK0523013T3 (da) 1995-05-08
JPH05194216A (ja) 1993-08-03
KR930001906A (ko) 1993-02-22
CA2072911A1 (en) 1993-01-05
ITMI911845A1 (it) 1993-01-05
DE69200948T2 (de) 1995-05-18
EP0523013A2 (de) 1993-01-13
HUT61462A (en) 1993-01-28
NO922635D0 (no) 1992-07-03
IL102381A0 (en) 1993-01-14

Similar Documents

Publication Publication Date Title
ATE73657T1 (de) Verwendung von gamma-linolensaeure und verwandten verbindungen zur herstellung eubnes arzneimittels zur behandlung von endometriose.
NO890259L (no) Fremgangsmaate for fremstilling av terapeutisk aktive etylfenoksyacetamider.
FR2680507B1 (fr) Nouvelles naphtylethylurees et naphtylethylthiourees, leur procede de preparation et les compositions pharmaceutiques qui les contiennent.
NO902800D0 (no) Fremgangsmaate for fremstilling av 11beta-aryl-4-oestrener.
ATE181237T1 (de) Substituierte cyclohexan-derivate zur behandlung von krankheiten
DE3688721T2 (de) Verwendung von Porphyrinderivaten bei der Entdeckung und Behandlung von Tumoren.
EP0328634A4 (en) Pharmaceutical compositions for the treatment of psoriasis
DE69431199T2 (de) Melatonin-Derivate zur Verwendung in der Behandlung von Schlafstörungen
ATE74605T1 (de) Tetracyclische chinazolinderivate, herstellung und verwendung.
DE69200948D1 (de) Verwendung von Benzimidazolin-2-oxo-1-Carbonsäurederivaten bei der Behandlung organischer Gehirnerkrankungen.
ATE73785T1 (de) 5-(3-alkyl-5-tert.butyl-4-hydroxyphenyl)-2-amin - 6h-1,3,4-thiadiazine, verfahren zu ihrer herstellung, die sie enthaltenden arzneimittel und ihre verwendung.
ATE82850T1 (de) Verwendung von 2-pyrimidinyl-1-piperazinderivaten.
ATE100102T1 (de) Substituierte derivate von 20,21dinoreburnamenin, verfahren zur herstellung und so hergestellte zwischenprodukte, ihre verwendung als arzneimittel und diese enthaltende pharmazeutische zusammenstellungen.
ATE88176T1 (de) 2-hydroxy-3-aryloxy-propylaminderivate mit kardiovaskulaerer wirkung.
DE69124415T2 (de) Verwendung von 15-Dehydroxy-16-Oxoprostaglandin bei der Behandlung von allergischen Erkrankungen
ATE119149T1 (de) Pyrrolidonderivate, verfahren zu ihrer herstellung und sie enthaltende arzneimittel.
DE59003446D1 (de) 13-Brom und 13, 14-Dibrom-Ergoline, ihre Herstellung und Verwendung in Arzneimitteln.
IT1241927B (it) 3'-deamino-4'-deossi-4'-amino-8-fluoroantra- cicline processi per la loro preparazione e composizioni farmaceutiche che le contengono
NO163283C (no) Analogifremgangsm te til fremstilling av terapeutisk aktive n-bicykloheptyl og n-bicykloheptenylimidazoler.
ATE117896T1 (de) Arzneimittel welche substituierte 2-cyclohexen- 1yl-amin-derivate enthalten und ihre verwendung zur bekämpfung von krankheiten.
DK159118C (da) 6alfa-methylprednisolon-derivater og farmaceutiske praeparater der indeholder dem
ATE30032T1 (de) N-acylderivate von dipeptiden, ihre herstellung und verwendung bei der therapie von krankheiten und mittel dafuer.

Legal Events

Date Code Title Description
8364 No opposition during term of opposition
8339 Ceased/non-payment of the annual fee